Both our CEO and CTO were involved in a gut-brain study published in the prestigious Nature Aging, led by the John Cryan Lab at APC Microbiome Ireland. By transplanting microbes from young into old animals it was possible to rejuvenate aspects of brain and immune function. This could be a potential game changer, as the microbiome could be harnessed to reverse age-related brain deterioration. There was also evidence of improved learning ability and cognitive function
The team of SeqBiome CTO, Prof Paul Cotter, have continued to be very active in recent months publishing multiple papers relating to food chain, food, animal and human microbiomes. This includes the monitoring of the microbiomes foods (here, here and here), food processing facilities, porcine, vaginal, and lung microbiomes, as well as the impact of diet on human gut microbiomes (here and here).
The use of Machine Learning (ML) carries enormous potential, but also challenges, for making the most out of microbiome studies. SeqBiome CEO is also Chair of the EU COST Action ML4Microbiome who recently published two reviews in Frontiers in Microbiology on the current state-of-the-art of ML in microbiome research, read more here and here.
As the only Irish participant, SeqBiome is one of 10 start-ups selected from over 200 applicants to partake in the prestigious PepsiCo’s Greenhouse Accelerator program.
The program, which is now in its fifth year, seeks to support the acceleration of ingredients, products or services that encourage a healthy lifestyle and enable health management and wellness on a global scale.
This accelerator program will help SeqBiome to develop our microbiome expertise into a competitive offering to both professional and amateur health, as well as sports-focused consumers, to improve or maintain their physical and mental performance
Read more in the Forbes.
SeqBiome CTO and co-founder Prof Paul Cotter is a co-author of the recent International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods published in Nature Reviews Gastroenterology and Hepatology. This is just one of a number of recent papers from Paul’s team relating to fermented foods, including the most detailed study to date of cheese microbiomes in Nature Food, an assessment of the impact of a fermented food (kefir) of gut-brain modules in mice, investigation of the overlap between LAB (lactic acid bacteria) found in fermented foods and the gut and a survey of a broad variety of fermented food microbiomes.
SeqBiome CTO and co-founder Prof Paul Cotter leads the Irish Coronavirus Sequencing Consortium, see here for more details. There is also an interview in the Irish Examiner about the consortium and Paul also provided an overview of the consortium for RTE’s ‘10Things to Know About’ programme.
Paul Cotter, SeqBiome CTO, was one of the 33 Ireland-based researchers to be named on Clarivate’s 2020 list of Highly Cited researchers. This is the third consecutive year that Paul was included on this list.
SeqBiome Ltd. is today launched after spinning out from APC Microbiome Ireland, SFI Research Centre, University College Cork and Teagasc (the Irish Agriculture and Food Development Authority).
SeqBiome provides high-quality and interactive sequencing and microbiome analysis for academia and industry. The offering is comprehensive and spans the microbiome project continuum with an aim of creating meaningful microbiome insights for clients across industries such as Pharmaceuticals, Nutrition, Sport, Healthcare, Agriculture and other Life Sciences.
SeqBiome CTO and co-founder Prof Paul Cotter contributes to investigating the impacts of the fermented milk, kefir, on the behaviour and the gut-brain axis published in Microbiome (https://doi.org/10.1038/s41467-020-16438-8). For a video summary see https://youtu.be/DP2CLSr0zV8
SeqBiome CEO and co-founder Dr Marcus Claesson publish two large microbiome studies on inflammatory bowel disease in Nature Communications and Gut.
Read more in NutraIngredients.
SeqBiome CTO and co-founder Prof Paul Cotter involved in a study to investigate the overlap between fermented food and human gut microbiomes Nature Communications.
SeqBiome CTO and co-founder Prof Paul Cotter has been funded by Science Foundation Ireland to lead a national consortium involving multiple research institutes and hospitals to carry out sequencing of the SARS-CoV-2 virus (https://doi.org/10.1186/s40168-020-00846-5).